Sign in

CIK 0001601485

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Elicio Therapeutics, Inc.

Sign in to watch
Ticker
ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113430072
Phone
+1 857-209-0050
Business address
451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
Former names
Angion Biomedica Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Venkatesan Jay bought 277,244 shares at an average $2.63 ($730,373)
  6. 4 Open-market buy Venkatesan Jay bought 3,527 shares at $2.54 ($8,976)
  7. 4 Open-market sale Neylan John F. sold 358 shares at $2.62 ($938)
  8. 4 Open-market buy Venkatesan Jay bought 41,625 shares at an average $2.55 ($105,951)
  9. 4 Open-market buy Venkatesan Jay bought 77,604 shares at $2.41 ($186,956)
  10. 4 Open-market buy CURHAN GREGORY S bought 4,000 shares at $2.37 ($9,480)
  11. 4 Open-market sale Rhodes Jennifer J sold 451 shares at $2.42 ($1,090)
  12. 4 Open-market sale Goldberg Itzhak sold 32,118 shares at $3.35 ($107,721)
  13. 4 Open-market sale Goldberg Itzhak sold 117,882 shares at an average $3.48 ($410,211)
  14. 4 Open-market sale Neylan John F. sold 374 shares at $4.13 ($1,545)
  15. 4 Open-market sale Goldberg Itzhak sold 150,000 shares at an average $4.19 ($629,051)
  16. 4 Open-market sale Rhodes Jennifer J sold 433 shares at $4.40 ($1,905)
  17. 4 Open-market sale Neylan John F. sold 373 shares at $8.62 ($3,215)
  18. 4 Open-market sale Rhodes Jennifer J sold 430 shares at $8.65 ($3,720)
  19. 4 Open-market sale Neylan John F. sold 376 shares at $10.07 ($3,786)
  20. 4 Open-market sale Rhodes Jennifer J sold 430 shares at $10.64 ($4,575)

Page 5 of 7 · 140 filings